Unknown Company
Lead late-stage drug substance process development and CMC strategy. Manage tech transfer and PPQ activities across CDMOs. What We Look For: 8+ years in pharmaceutical drug substance development with R&D and GMP expertise. Strong CDMO oversight, regulatory CMC, and QbD/DoE experience. Why Pulmovant: Work on a Phase 3 asset with strong clinical data. Join a collaborative Roivant-backed biotech culture. Pulmovant is a Roivant-backed clinical-stage biotech developing inhaled therapies for pulmonary diseases. Its lead candidate, mosliciguat, is in Phase 3 for PH-ILD, and the company operates with a collaborative, fast-paced Roivant culture. #J-18808-Ljbffr
Associate Director, Drug Substance (Process Chemistry) (Fully Remote) in workfromhome at Unknown Company
This position is listed as full time and onsite.